Status:

RECRUITING

Social and Environmental Determinants of Breast Cancer Survivorship: the Black Breast Cancer Survivor's Intervention (BBCSI)

Lead Sponsor:

M.D. Anderson Cancer Center

Conditions:

Breast Cancer

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

The goal of this research study is to learn about the effects of the BBCSI course on the quality of life of Black breast cancer survivors. A community-based and peer-led Black Breast Cancer Survivor'...

Detailed Description

Primary Objectives: Guided by the Transcreation Framework for Community-engaged Behavioral Interventions to Reduce Health Disparities (Transcreation Framework), the overall purpose of this study is t...

Eligibility Criteria

Inclusion

  • Participants:
  • To be eligible to participate in this study, an individual must meet all the following criteria:
  • Adult women aged 18 years and older
  • Histologically confirmed stage 0-III breast cancer
  • No evidence of metastatic disease
  • Within four-years of diagnosis
  • Self-identify as Black
  • Able to communicate in English
  • Community Interventionists:
  • To be eligible to participate in this study, an individual must meet all the following criteria:
  • Adult women aged 18 years and older
  • Histologically confirmed stage 0-III breast cancer
  • No evidence of metastatic disease
  • Self-identify as Black
  • Able to communicate in English

Exclusion

  • Men or woman below 18 years of age
  • Does not have a histologically confirmed breast cancer
  • There's evidence of metastatic disease
  • More than four-years of diagnosis
  • Does not self-identify as Black
  • Unable to communicate in English

Key Trial Info

Start Date :

August 27 2025

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

August 31 2029

Estimated Enrollment :

48 Patients enrolled

Trial Details

Trial ID

NCT06885203

Start Date

August 27 2025

End Date

August 31 2029

Last Update

January 9 2026

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

The University of Texas M. D. Anderson Cancer Center

Houston, Texas, United States, 77030